Literature DB >> 1736297

Long-term expression of human adenosine deaminase in vascular smooth muscle cells of rats: a model for gene therapy.

C M Lynch1, M M Clowes, W R Osborne, A W Clowes, A D Miller.   

Abstract

Gene transfer into vascular smooth muscle cells in animals was examined by using recombinant retroviral vectors containing an Escherichia coli beta-galactosidase gene or a human adenosine deaminase (adenosine aminohydrolase, EC 3.5.4.4) gene. Direct gene transfer by infusion of virus into rat carotid arteries was not observed. However, gene transfer by infection of smooth muscle cells in culture and seeding of the transduced cells onto arteries that had been denuded of endothelial cells was successful. Potentially therapeutic levels of human adenosine deaminase activity were detected over 6 months of observation, indicating the utility of vascular smooth muscle cells for gene therapy in humans.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1736297      PMCID: PMC48401          DOI: 10.1073/pnas.89.3.1138

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Improved retroviral vectors for gene transfer and expression.

Authors:  A D Miller; G J Rosman
Journal:  Biotechniques       Date:  1989-10       Impact factor: 1.993

2.  Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B.

Authors:  T D Palmer; A R Thompson; A D Miller
Journal:  Blood       Date:  1989-02       Impact factor: 22.113

3.  Recombinant gene expression in vivo within endothelial cells of the arterial wall.

Authors:  E G Nabel; G Plautz; F M Boyce; J C Stanley; G J Nabel
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

4.  Implantation of vascular grafts lined with genetically modified endothelial cells.

Authors:  J M Wilson; L K Birinyi; R N Salomon; P Libby; A D Callow; R C Mulligan
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

5.  Factors involved in production of helper virus-free retrovirus vectors.

Authors:  A D Miller; D R Trauber; C Buttimore
Journal:  Somat Cell Mol Genet       Date:  1986-03

6.  HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization.

Authors:  T Tsukada; D Tippens; D Gordon; R Ross; A M Gown
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

7.  Expression of human adenosine deaminase from various strong promoters after gene transfer into human hematopoietic cell lines.

Authors:  R A Hock; A D Miller; W R Osborne
Journal:  Blood       Date:  1989-08-01       Impact factor: 22.113

8.  Efficient retrovirus-mediated transfer and expression of a human adenosine deaminase gene in diploid skin fibroblasts from an adenosine deaminase-deficient human.

Authors:  T D Palmer; R A Hock; W R Osborne; A D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

9.  Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA.

Authors:  J Pelletier; N Sonenberg
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

10.  Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos.

Authors:  J R Sanes; J L Rubenstein; J F Nicolas
Journal:  EMBO J       Date:  1986-12-01       Impact factor: 11.598

View more
  13 in total

1.  Novel methods for adenovirus-mediated gene transfer to blood vessels in vivo.

Authors:  H Ooboshi; C D Ríos; D D Heistad
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

Review 2.  Gene therapy.

Authors:  S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

3.  Prolonged survival and improved glycemia in BioBreeding diabetic rats after early sustained exposure to glucagon-like peptide 1.

Authors:  Ofer Yanay; Daniel Moralejo; Kelly Kernan; Margaret Brzezinski; Jessica M Fuller; Randall W Barton; Ake Lernmark; William R Osborne
Journal:  J Gene Med       Date:  2010-06       Impact factor: 4.565

Review 4.  Current aspects of gene therapy: implications for vascular interventions.

Authors:  F Reifers; J Kreuzer
Journal:  J Mol Med (Berl)       Date:  1995-12       Impact factor: 4.599

Review 5.  Gene transfer to the vasculature: historical perspective and implication for future research objectives.

Authors:  Sarah J George; Andrew H Baker
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

6.  Therapeutic approaches to the control of fibrocellular intimal hyperplasia after angioplasty.

Authors:  J McEwan
Journal:  Br Heart J       Date:  1993-07

7.  Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity.

Authors:  A H Schulick; G Vassalli; P F Dunn; G Dong; J J Rade; C Zamarron; D A Dichek
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

Review 8.  Gene therapy for vascular diseases.

Authors:  K K Wu; P Zoldhelyi; J T Willerson; X M Xu; D S Loose-Mitchell; L H Wang
Journal:  Tex Heart Inst J       Date:  1994

9.  Gene therapy for long-term expression of erythropoietin in rats.

Authors:  W R Osborne; N Ramesh; S Lau; M M Clowes; D C Dale; A W Clowes
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

10.  Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth.

Authors:  R Morishita; G H Gibbons; R E Pratt; N Tomita; Y Kaneda; T Ogihara; V J Dzau
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.